4//SEC Filing
Sobel Alan D. 4
Accession 0001104659-25-075790
CIK 0001175151other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 7:33 PM ET
Size
14.0 KB
Accession
0001104659-25-075790
Insider Transaction Report
Form 4
Sobel Alan D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-08-08+22,000→ 22,000 totalExercise: $1.00Exp: 2035-08-08→ Common Stock (22,000 underlying)
Holdings
- 145,757
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Includes (i) the following restricted stock units ("RSUs") that will be settled into Common Stock upon vesting upon a "Change in Control" of the Company, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 3,300 RSUs granted on March 15, 2018, (b) 6,000 RSUs granted on February 24, 2017, (c) 5,000 RSUs granted on June 7, 2016, and (d) 55,000 RSUs granted on April 8, 2015 and (ii) 76,457 shares of Common Stock owned directly by the Reporting Person.
- [F2]These shares are held in the Bernard Sobel Revocable Trust (the "Trust"), for which the Reporting Person is a trustee and a named beneficiary. Accordingly, the Reporting Person may be deemed the beneficial owner of the shares held in the Trust.
- [F3]The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four (4) equal quarterly installments over a period of one year following the date of grant, subject to the reporting person's continued service as of the applicable vesting date.
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001639386
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 7:33 PM ET
- Size
- 14.0 KB